[Federal Register: November 21, 2002 (Volume 67, Number 225)]
[Notices]
[Page 70234-70235]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21no02-99]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Recombinant DNA Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Recombinant DNA Advisory Committee.
Date: December 4-6, 2002.
Time: December 4, 2002, 1 pm to 5:15 pm.
Agenda: The Committee will discuss a clinical trial for X-linked
SCID, and selected safety and protocol data related to human gene
transfer clinical trials.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Agenda: The Committee will discuss a clinical trial for X-linked
SCID, selected safety and protocol data related to human gene
transfer clinical trials, and review selected human gene transfer
protocols.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Time: December 6, 2002, 8:30 am to 1 pm.
Agenda: The Committee will review selected human gene transfer
protocols.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: Stephen M. Rose, Phd, Executive Secretary,
Office of Biotechnology Activities, National Institutes of Health,
6705 Rockledge Drive, Room 750, Bethesda, MD 20892, 301-496-9838,
sr8j@nih.gov.
Information is also available on the Institute's/Center's home
page: www4.od.nih.gov/oba/, where an agenda and any additional
information for the meeting will be posted when available.
OMB's ``Mandatory Information Requirements for Federal
Assistance Program Announcements'' (45 FR 39592, June 11, 1980)
requires a statement concerning the official government programs
contained in the Catalog of Federal Domestic Assistance. Normally
NIH lists in its announcements the number and title of affected
individual programs for the guidance of the public. Because the
guidance in this notice covers virtually every NIH and Federal
research program in which DNA recombinant molecule techniques could
be used, it has been determined not to be cost effective or in the
public interest to attempt to list these programs. Such a list would
likely require several additional pages. In addition, NIH could not
be certain that every Federal program would be included as many
Federal agencies, as well as private organizations, both national
and international, have elected
[[Page 70235]]
to follow the NIH Guidelines. In lieu of the individual program
listing. NIH invites readers to direct questions to the information
address above about whether individual programs listed in the
Catalog of Federal Domestic Assistance are affected.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.187, Undergraduate
Scholarship Program for Individuals from Disadvantaged Backgrounds;
93.22, Clinical Research Loan Repayment Program for Individuals from
Disadvantaged Backgrounds; 93.232, Loan Repayment Program for
Research Generally; 93.39, Academic Research Enhancement Award; NIH
Acquired Immunodeficiency Syndrome Research Loan Repayment Program,
National Institutes of Health, HHS)
Dated: November 14, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-29549 Filed 11-20-02; 8:45 am]
BILLING CODE 4140-01-M